Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000946644-05-000017
Filing Date
2005-11-18
Accepted
2005-11-18 14:11:10
Documents
8
Effectiveness Date
2005-11-18

Document Format Files

Seq Description Document Type Size
1 rs8_1105.txt S-8 124581
2 rexh_41.txt EX-99.77Q1 OTHR EXHB 30302
3 rexh_42.txt EX-99.77Q1 OTHR EXHB 30155
4 rexh_43.txt EX-99.77Q1 OTHR EXHB 29957
5 rexh_44.txt EX-99.77Q1 OTHR EXHB 31164
6 rexh_45.txt EX-99.77Q1 OTHR EXHB 31263
7 rexh_51.txt EX-99.2L OPIN COUNSL 3597
8 rexh_bdo.txt EX-99.77B ACCT LTTR 871
  Complete submission text file 0000946644-05-000017.txt   283450
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-129811 | Film No.: 051214851
SIC: 2836 Biological Products, (No Diagnostic Substances)